Hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli 0111

Reza Azadi, Kenneth Calabrese, Jeffrey Stroup

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Shiga toxin-producing Escherichia coli (STEC) was first discovered in 1977 and since has caused serious complications including the life-threatening condition of hemolytic uremic syndrome (HUS). While HUS is most common in children, adults and especially elderly patients experience a higher incidence of death and disability. Because the majority of HUS cases have been described in children, pediatric treatment options have been used to treat adult and elderly patients with HUS. More research regarding the treatment, risk factors, and prognosis of HUS in adults needs to be performed to ensure that optimal care is provided. The authors present a case series of 5 adults with HUS who were part of the largest outbreak of E coli 0111 reported in the United States. To date, there are no published cases of HUS secondary to E coli 0111 in adults. The authors also include a literature review of HUS secondary to STEC.

Original languageEnglish
Pages (from-to)538-544
Number of pages7
JournalJournal of the American Osteopathic Association
Volume110
Issue number9
StatePublished - 1 Sep 2010

Fingerprint

Shiga-Toxigenic Escherichia coli
Hemolytic-Uremic Syndrome
Escherichia coli
Disease Outbreaks
Pediatrics
Incidence

Cite this

@article{3746df38ef2b4bf49b5c8623960681a2,
title = "Hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli 0111",
abstract = "Shiga toxin-producing Escherichia coli (STEC) was first discovered in 1977 and since has caused serious complications including the life-threatening condition of hemolytic uremic syndrome (HUS). While HUS is most common in children, adults and especially elderly patients experience a higher incidence of death and disability. Because the majority of HUS cases have been described in children, pediatric treatment options have been used to treat adult and elderly patients with HUS. More research regarding the treatment, risk factors, and prognosis of HUS in adults needs to be performed to ensure that optimal care is provided. The authors present a case series of 5 adults with HUS who were part of the largest outbreak of E coli 0111 reported in the United States. To date, there are no published cases of HUS secondary to E coli 0111 in adults. The authors also include a literature review of HUS secondary to STEC.",
author = "Reza Azadi and Kenneth Calabrese and Jeffrey Stroup",
year = "2010",
month = "9",
day = "1",
language = "English",
volume = "110",
pages = "538--544",
journal = "Journal of the American Osteopathic Association",
issn = "0098-6151",
publisher = "American Osteopathic Association",
number = "9",

}

Hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli 0111. / Azadi, Reza; Calabrese, Kenneth; Stroup, Jeffrey.

In: Journal of the American Osteopathic Association, Vol. 110, No. 9, 01.09.2010, p. 538-544.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli 0111

AU - Azadi, Reza

AU - Calabrese, Kenneth

AU - Stroup, Jeffrey

PY - 2010/9/1

Y1 - 2010/9/1

N2 - Shiga toxin-producing Escherichia coli (STEC) was first discovered in 1977 and since has caused serious complications including the life-threatening condition of hemolytic uremic syndrome (HUS). While HUS is most common in children, adults and especially elderly patients experience a higher incidence of death and disability. Because the majority of HUS cases have been described in children, pediatric treatment options have been used to treat adult and elderly patients with HUS. More research regarding the treatment, risk factors, and prognosis of HUS in adults needs to be performed to ensure that optimal care is provided. The authors present a case series of 5 adults with HUS who were part of the largest outbreak of E coli 0111 reported in the United States. To date, there are no published cases of HUS secondary to E coli 0111 in adults. The authors also include a literature review of HUS secondary to STEC.

AB - Shiga toxin-producing Escherichia coli (STEC) was first discovered in 1977 and since has caused serious complications including the life-threatening condition of hemolytic uremic syndrome (HUS). While HUS is most common in children, adults and especially elderly patients experience a higher incidence of death and disability. Because the majority of HUS cases have been described in children, pediatric treatment options have been used to treat adult and elderly patients with HUS. More research regarding the treatment, risk factors, and prognosis of HUS in adults needs to be performed to ensure that optimal care is provided. The authors present a case series of 5 adults with HUS who were part of the largest outbreak of E coli 0111 reported in the United States. To date, there are no published cases of HUS secondary to E coli 0111 in adults. The authors also include a literature review of HUS secondary to STEC.

UR - http://www.scopus.com/inward/record.url?scp=79958285585&partnerID=8YFLogxK

M3 - Article

C2 - 20876839

AN - SCOPUS:79958285585

VL - 110

SP - 538

EP - 544

JO - Journal of the American Osteopathic Association

JF - Journal of the American Osteopathic Association

SN - 0098-6151

IS - 9

ER -